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21 Down syndrome (DS) is characterised by abnormal cognitive and motor development, and 
22 later in life by progressive Alzheimer’s disease (AD)-like dementia, neuropathology, declining 
23 motor function and shorter life expectancy. It is caused by trisomy of chromosome 21 (Hsa21), 
24 but how individual Hsa21 genes contribute to various aspects of the disorder is incompletely 
25 understood. Previous work has demonstrated a role for triplication of the Hsa21 gene DYRK1A 
26 in cognitive and motor deficits, as well as in altered neurogenesis and neurofibrillary 
27 degeneration in the DS brain, but its contribution to other DS phenotypes is unclear. Here we 
28 demonstrate that overexpression of minibrain (mnb), the Drosophila ortholog of DYRK1A, in 
29 the Drosophila nervous system accelerated age-dependent decline in motor performance and 
30 shortened lifespan. Overexpression of mnb in the eye was neurotoxic and overexpression in 
31 ellipsoid body neurons in the brain caused age-dependent neurodegeneration. At the larval 
32 neuromuscular junction, an established model for mammalian central glutamatergic synapses, 
33 neuronal mnb overexpression enhanced spontaneous vesicular transmitter release. It also 
34 slowed recovery from short-term depression of evoked transmitter release induced by high-
35 frequency nerve stimulation and increased the number of boutons in one of the two 
36 glutamatergic motor neurons innervating the muscle. These results provide further insight into 
37 the roles of DYRK1A triplication in abnormal aging and synaptic dysfunction in DS.
3
39 Highlights
40 • Overexpression of minibrain (DYRK1A) causes Down’s relevant phenotypes including:
41 • Age-dependent degeneration of brain neurons 
42 • Accelerated age-dependent decline in motor performance and shorted lifespan
43 • Modified presynaptic structure and enhanced spontaneous transmitter release 
44 • Slowed recovery from short-term depression of synaptic transmission
45
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55 Introduction 
56 Down syndrome (DS, also known as Down’s syndrome) or trisomy 21 is caused by the 
57 presence of three copies of chromosome 21 (Hsa21) instead of the usual two (Herault et al., 
58 2017). It is characterised by cognitive impairment (Lott and Dierssen, 2010) and the delayed 
59 and incomplete acquisition of motor skills (Malak et al., 2015) as a result of abnormal 
60 development of the nervous system (Stagni et al., 2018). Individuals with DS almost invariably 
61 develop Alzheimer’s disease (AD)-like symptoms (AD-DS). These include progressive 
62 dementia after 40 years of age, the onset of amyloid plaques, neurofibrillary tangles (NFTs) 
63 and neurodegeneration after 10 – 20 years (Wiseman et al., 2015; Zigman, 2013), faster age-
64 dependent motor decline that is an early marker for the onset of cognitive decline and health 
65 deterioration (Anderson-Mooney et al., 2016; Buchman and Bennett, 2011), and a shorter 
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66 mean life expectancy by approximately 28 years (O'Leary et al., 2018). Currently there is no 
67 treatment for DS or AD; our understanding of the mechanisms of the disorder is incomplete 
68 and this hampers the development of effective therapies.
69
70 One of the Hsa21 genes, DYRK1A (dual specificity tyrosine-phosphorylation-regulated kinase 
71 1A), is a candidate causative gene for the structural and functional changes that occur in the 
72 DS brain, and for the associated cognitive and motor deficits (Herault et al., 2017; Stagni et 
73 al., 2018). DYRK1A/Dyrk1a mRNA and protein are expressed throughout the brain in humans 
74 and rodents, wherein DYRK1A controls aspects of neuronal development and function 
75 (Duchon and Herault, 2016; Kay et al., 2016; Stringer et al., 2017). DYRK1A/Dyrk1a mRNA 
76 and protein expression is increased in DS brain and in the brain of different mouse models of 
77 DS (Duchon and Herault, 2016; Garcia-Cerro et al., 2018; Kay et al., 2016; Stringer et al., 
78 2017), whether the gene is triplicated as part of a genomic segment, as in Dp1Yey, Ts65Dn, 
79 Ts1Cje and Tc1 mice, or alone as in TgDyrk1a and TgDYRK1A mice (Herault et al., 2017). 
80
81 DS-associated cognitive and motor deficits are replicated by overexpression of Dyr1ka in mice 
82 (Ahn et al., 2006; Altafaj et al., 2001; Altafaj et al., 2013; Arque et al., 2013; García-Cerro et 
83 al., 2014; Garcia-Cerro et al., 2018; Martínez de Lagrán et al., 2004; Ortiz-Abalia et al., 2008; 
84 Souchet et al., 2014; Watson-Scales et al., 2018). However, the contribution of DYRK1A 
85 overexpression to the shorter life expectancy, faster age-dependent decline in cognitive and 
86 motor function, and development of AD-like pathology in DS is unclear.  It is predicted to play 
87 a role as it both phosphorylates tau and alters its splicing (Shi et al., 2008; Woods et al., 2001), 
88 promoting its self-aggregation (Liu et al., 2008) into NFTs. Dyrk1A is found physically 
89 associated with NFTs in the brain to a greater level in DS-AD than non-DS associated AD 
90 (Wegiel et al., 2008; Wegiel et al., 2011). In the Ts65Dn and Ts1Cje mouse models of DS, 
91 Dyrk1a overexpression in the brain intensifies with age (Ahmed et al., 2017; Creau et al., 2016; 
92 Stringer et al., 2017; Watson-Scales et al., 2018), and this is associated with AD-DS-like 
93 histopathological changes in the aged Ts65Dn brain (García-Cerro et al., 2017; Wiseman et 
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94 al., 2015). However, there is insufficient behavioural data from aged animals to directly assess 
95 the impact of DYRK1A overexpression in inducing DS-AD phenotypes.
96
97 Cognitive and motor dysfunction in individuals with DS and in mouse models of DS are 
98 associated with changes in synaptic plasticity and with changes in the number and structure 
99 of GABAergic and glutamatergic brain neurons and synapses (Battaglia et al., 2008; 
100 Contestabile et al., 2017; Duchon and Herault, 2016). Such modifications have been linked to 
101 Dyrk1a overexpression (Duchon and Herault, 2016; García-Cerro et al., 2017; Garcia-Cerro 
102 et al., 2018; Ruiz-Mejias et al., 2016), but the effects of Dyrk1a overexpression on the basic 
103 properties of synaptic function have rarely been explored. In one study, there was no change 
104 in the frequency of miniature excitatory synaptic currents (mEPSCs) or the probability of 
105 electrically-evoked glutamate release in the prefrontal cortex of TgDyrk1a mice (Thomazeau 
106 et al., 2014). Nevertheless, since Dyrk1a controls the activity of proteins that regulate 
107 endocytosis (Murakami et al., 2012) and DYRK1A overexpression slows endocytosis of 
108 transmitter vesicles in hippocampal presynaptic membranes from TgDYRK1A mice (Kim et 
109 al., 2010), modulation of transmitter release at other glutamatergic synapses is likely.
110
111 To investigate the contribution of DYRK1A overexpression in the nervous system to various 
112 aspects of DS, we overexpressed minibrain (mnb), the Drosophila ortholog of DYRK1A 
113 (Duchon and Herault, 2016), in the Drosophila nervous system and implemented well-
114 established assays in larvae and adult flies (Bykhovskaia and Vasin, 2017; Lenz et al., 2013; 
115 McGurk et al., 2015). The assays monitored motor impairment and its development with age, 
116 lifespan, age-related neurodegeneration, and synaptic dysfunction. Due to their short lifecycle, 
117 Drosophila are one of the pre-eminent models for aging and neurodegeneration (Jones and 
118 Grotewiel, 2011), both aspects of DS that are more difficult to investigate in mice. The 
119 Drosophila larval neuromuscular junction (NMJ) is a well-established model for mammalian 
120 central glutamatergic synapses and is easily accessible to electrophysiology (Bykhovskaia 
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121 and Vasin, 2017). Mnb is expressed presynaptically at larval NMJs and reducing its expression 
122 changes motor nerve terminal structure and impairs recycling of transmitter vesicles, while 
123 overexpression of one isoform, mnb-F, has no effect on basal transmission but ameliorates 
124 the effects of reduced mnb expression (Chen et al., 2014). Five mnb isoforms, E-I, have been 
125 identified, all of which share a highly conserved kinase domain (Gramates et al., 2017; Hong 
126 et al., 2012). Regions of DYRK1A outside the kinase domain also appear to play important 
127 roles, but which areas exactly and how they impact function is thus far incompletely 
128 understood (Jin et al., 2015; Kelly and Rahmani, 2005; von Groote-Bidlingmaier et al., 2003). 
129 We therefore utilised mnb-H, the isoform with the longest coding region (Gramates et al., 2017; 
130 Zerbino et al., 2018). Here we report the effects of neuronal overexpression of mnb-H on motor 
131 function, the rate of motor decline with age, lifespan, age-related neurodegeneration, 
132 presynaptic structure, spontaneous transmitter release and recovery from frequency-





137 Neuronal overexpression of mnb produced motor deficits in larvae, accelerated age-
138 dependent motor decline in adult flies and shortened adult lifespan
139 The effect of mnb overexpression in the nervous system on motor function (specifically the 
140 mnb-H splice variant) was tested using two assays of fly larval locomotion. Elav>mnb larvae, 
141 overexpressing mnb throughout the nervous system under the control of the Elav-Gal4 driver 
142 (Robinow and White, 1991), did not move as far as control larvae (Elav/+) in a free movement 
143 assay (Fig. 1A), which measures the ability of larvae to perform rhythmic muscle contractions 
144 necessary for gross locomotion (Kohsaka et al., 2017). They also took longer to complete a 
145 self-righting assay (Fig. 1B), which is a more complex motor task requiring larvae to enact a 
146 co-ordinated sequence of movements to right themselves after being rolled onto their backs 
147 (Picao-Osorio et al., 2015). To assess the impact of neuronal mnb overexpression on age-
148 related decline in locomotor function, the performance of the same cohorts of adult flies was 
149 assessed in a negative geotaxis assay at different ages (Jones and Grotewiel, 2011). This 
150 showed acceleration in Elav>mnb flies of the usual age-related decline in performance 
151 (Elav/+). There was also evident shortening of the lifespan of Elav>mnb flies, so that the 
152 median lifespan was reduced by almost 50% (Elav/+, 73 days; Elav>mnb, 38 days; Fig. 1D). 
153 These results indicate that neuronal overexpression of mnb alone produced a motor deficit 
154 and abnormal aging characterised by accelerated age-related locomotor impairment and a 
155 shorter lifespan.
156
157 Overexpression of mnb caused neurodegeneration in adult flies
158 As DYRK1A triplication has been linked to degeneration of brain neurons in AD-DS and in 
159 Ts65Dn mice (García-Cerro et al., 2017; Wegiel et al., 2008), we tested the possibility that 
160 neuronal overexpression of mnb is sufficient to cause neurotoxicity and age-related 
161 neurodegeneration using two established assays of neurodegeneration in adult flies (Lenz et 
162 al., 2013; McGurk et al., 2015). In the first, mnb was overexpressed in the eye through 
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163 development and adulthood using the Glass multimer reporter driver (GMR-Gal4) (Ellis et al., 
164 1993). The GMR>mnb flies, but not control flies (GMR/+), had a reduced eye surface area 
165 and a visible “rough eye” phenotype (Fig. 2A), both of which indicate neural death and the 
166 resultant breakdown of the regularly spaced array of ommatidia making up the retina. In a 
167 second assay, the EB1 driver (EB1-Gal4) was used to overexpress mnb in the ellipsoid body 
168 (EB), a subpopulation of neurons within the central complex of the brain implicated in 
169 locomotor control (Fig. 2B) (Diaper et al., 2013). The EB cells also expressed membrane-
170 bound GFP which enabled their visualisation. At 1 day old, there was no difference in the 
171 number of GFP-positive EB neurons between control (EB1/+) and EB1>mnb flies, whereas at 
172 day 40 the number of EB neurons was significantly reduced in EB1>mnb flies but not in control 
173 flies (Fig. 2C). Therefore, neurotoxicity caused by mnb overexpression promoted age-related 
174 neurodegeneration in a central neuron population.
175
176 Overexpression of mnb in motor neurons increased the number of synaptic boutons at 
177 the larval NMJ
178 To investigate the effect of mnb overexpression on presynaptic morphology, mnb was 
179 overexpressed in glutamatergic motor neurons of Drosophila larvae using OK371-Gal4 (Mahr 
180 and Aberle, 2006). The neuronal membranes were labelled with horseradish peroxidase 
181 (HRP). The muscle is innervated by two motor neurons with functionally and structurally 
182 distinct presynaptic boutons; 1s (small) boutons have higher excitation thresholds, higher 
183 basal probability of release and induce larger post-synaptic potentials, while short-term and 
184 homeostatic plasticity are largely mediated by 1b (big) boutons (Atwood et al., 1997; Newman 
185 et al., 2017). These were differentiated by the stronger postsynaptic expression of Discs large 
186 (Dlg) opposite 1b boutons (Lahey et al., 1994)  Analysis of the NMJ in the second abdominal 
187 larval segment, A2, showed that mnb overexpression affected the morphology of the nerve 
188 terminals of only one of the motor neurons; it increased the number of 1b boutons but did not 
189 alter the number of 1s boutons (Fig. 3A-B). The effect was not secondary to changes in muscle 
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190 size, as this did not differ (surface area of muscle 6: OK371/+, 44752 ± 1407 μm2, n = 15; 
191 OK371>mnb, 44681 ± 3684 μm2, n = 15, P = 0.9857). 
192
193 Overexpression of mnb in motor neurons altered basal synaptic transmission at the 
194 larval NMJ
195 As neuronal overexpression of mnb increased the number of 1b boutons at the larval NMJ, 
196 and because previous studies have implicated Dyrk1a/mnb in the control of the recycling of 
197 neurotransmitter vesicles (Chen et al., 2014; Kim et al., 2010; Murakami et al., 2012), we 
198 investigated if spontaneous glutamate release was altered by recording spontaneously 
199 occurring miniature excitatory junction potentials (mEJPs) with intracellular microelectrodes. 
200 Since the muscle 6/7 NMJ is innervated by 1b and 1s boutons, mEJPs usually result from the 
201 release of neurotransmitter vesicles from both types of boutons (Newman et al., 2017). Our 
202 recordings revealed that mEJPs occurred more frequently but were smaller in OK371>mnb 
203 larvae (Fig. 4A-B). The decrease in amplitude was not secondary to a change in the electrical 
204 properties of the muscle as there was no difference in input resistance (OK371/+, 3.37 ± 0.69 
205 MΩ, n = 8; OK371>mnb = 3.99 ± 0.99 MΩ, n = 8, P = 0.613) or resting potential (OK371/+, -
206 69.6 ± 1.48 mV, n = 8; OK371>mnb, -67.6 ± 1.55 mV, n = 8, P = 0.365). Although we did not 
207 directly investigate the source of the more frequent smaller mEJPs, the notion that they are 
208 due to the observed selective increase in the number of 1b boutons is suggested by the fact 
209 that 1b-dependent mEJPs are smaller than 1s-dependent mEJPs (Newman et al., 2017). In 
210 parallel with the changes in spontaneous synaptic events, there was a small (~11 %) decrease 
211 in the mean amplitude of electrically-evoked excitatory junction potentials (EJPs) caused by 
212 single stimuli applied to the nerve at a low frequency (0.1 Hz) (Fig. 4C). There was no 
213 difference between EJPs in mean rise time (OK371/+, 2.67 ± 0.178 ms, n = 8; OK371>mnb, 
214 3.23 ± 0.33 ms, n = 8, P = 0.728) or mean time constant of decay (OK371/+, 44.9 ± 3.1 ms, n 
215 = 8; OK371>mnb, 36.6 ± 4.6 ms, n = 8, P = 0.154). The relatively small fall in EJP amplitude 
216 is likely to reflect the smaller size of the 1b-dependent component of the EJP relative to that 
217 of the 1s-dependent component (Newman et al., 2017).  
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219 Overexpression of mnb in motor neurons slowed recovery from frequency-dependent 
220 depression at the larval NMJ
221 To investigate the effects of neuronal mnb overexpression on recycling of synaptic vesicles 
222 during electrically-evoked transmitter release, EJPs were evoked with pairs of electrical stimuli 
223 separated by intervals of varying duration (10 ms – 10 s) or with repeated trains of 10 stimuli 
224 applied at a high frequency (10 Hz, a frequency 100 times higher than that at which the single 
225 EJPs were evoked) (Kauwe and Isacoff, 2013). At control NMJs, paired pulses separated by 
226 intervals shorter than 200 ms caused depression of the amplitude of the second EJP relative 
227 to that of the first and the depression was stronger for shorter inter-stimulus intervals (Fig. 5A). 
228 The dependence of paired-pulse depression on interval duration was unaltered in 
229 OK371>mnb larvae (Fig. 5A), indicating that mnb overexpression did not alter release from a 
230 readily releasable pool of vesicles (Regehr, 2012). When transmitter release was evoked at 
231 control NMJs with a train of 10 stimuli at 10 Hz, there was rapid depression of the EJP 
232 amplitude by ~20% within the first 3 events (Fig. 5B). In the one-minute interval before the 
233 next train, the EJP amplitude recovered fully so that the amplitude of the first EJP in the second 
234 train was the same as in the first train (Fig. 5B). This ability to recover did not wane during the 
235 recording; the amplitude of the first EJP in each train did not differ between 8 trains (Fig. 5B). 
236 These effects are consistent with previous studies (Kauwe and Isacoff, 2013) and confirm 
237 rapid depletion and replenishment of the readily releasable pool of vesicles (Regehr, 2012). 
238 However, the same pattern of nerve stimulation produced different effects at OK371>mnb 
239 NMJs (Fig. 5B). The percentage decrease in EJP amplitude during each train was the same 
240 as at control NMJs, but the depression was not fully reversed during the intervals between 
241 trains, so that the first EJP in each train was smaller than the first EJP in the preceding train. 
242 The depression in amplitude accumulated over the 8 trains, resulting in an overall fall of 10%.  
243 To confirm that the changes in EJP amplitude were due to presynaptic changes in transmitter 
244 release and were not postsynaptically mediated by a decrease in the unitary depolarisations 
245 comprising each EJP, we measured the amplitudes of 200 mEJPs immediately before and 
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246 200 mEJPs immediately after the series of trains at each NMJ. At both control and 
247 OK371>mnb NMJs, the cumulative distribution of mEJP amplitudes before and after a series 
248 of trains was similar; although they were not identical, the observed slight increase in the 
249 number of larger mEJPs cannot explain the decline in EJP amplitude (Fig. 5C). These results 
250 show that mnb overexpression slowed replenishment of the readily releasable pool of vesicles, 
251 an effect consistent with the reported slowing of endocytosis of transmitter vesicles by 





256 This study demonstrated that neuronal overexpression of mnb, the Drosophila ortholog of 
257 DYRK1A, is sufficient to induce motor impairment, accelerate age-related decline in motor 
258 performance, shorten lifespan and cause age-dependent neurodegeneration. This study also 
259 found that neuronal mnb overexpression at a glutamatergic synapse alters presynaptic 
260 structure, modifies basal synaptic transmission and delays recovery from short-term synaptic 
261 depression. This provides useful information about the gene’s function and the pathological 
262 effects of increased expression in a model system. However, it is important to note that this 
263 does not represent a high-fidelity recapitulation of DS or the complexity of the human DYRK1A 
264 locus, because Gal4-mediated overexpression of a specific isoform does not accurately 
265 replicate the expression level or pattern caused by triplication of a whole genomic region of 
266 human chromosome 21. 
267
268 People with DS have impaired motor skills which are evident from childhood and are caused 
269 by abnormal development of the nervous system (Malak et al., 2015; Stagni et al., 2018). 
270 Later, in middle age, they undergo faster age-dependent motor decline, which is an early 
271 marker of future dementia, comorbidities and mortality, and is likely caused by 
272 histopathological changes in the brain (Anderson-Mooney et al., 2016; Buchman and Bennett, 
273 2011). The life expectancy of people with DS is about 28 years shorter than the general 
274 population (O'Leary et al., 2018). By taking advantage of the relatively short life cycle of 
275 Drosophila and transgenic overexpression of mnb in neurons, we have demonstrated a 
276 potential role for neuronal DYRK1A overexpression in the accelerated age-dependent decline 
277 of motor function and shortening of life expectancy in DS. The genetic basis of these aspects 
278 of DS are more difficult and costly to explore in mouse models of DS, due to the time required 
279 to study aged mice. Our finding that mnb overexpression causes age-related 
280 neurodegeneration confirms previous studies inferring a link between DYRK1A 
281 overexpression and degeneration and loss of neurons (Duchon and Herault, 2016; García-
282 Cerro et al., 2017; Watson-Scales et al., 2018; Wegiel et al., 2008), which is associated with 
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283 faster age-related decline in motor and cognitive function in DS and AD-DS. Our results also 
284 reinforce the conclusion from earlier studies with adult mice overexpressing DYRK1A or 
285 Dyrk1a, alone or as part of a chromosomal segment, that triplication of DYRK1A is likely to 
286 contribute to motor deficits in DS (Altafaj et al., 2001; Arque et al., 2013; Garcia-Cerro et al., 
287 2018; Martínez de Lagrán et al., 2004; Ortiz-Abalia et al., 2008; Souchet et al., 2014; Watson-
288 Scales et al., 2018). 
289
290 In addition to the smaller brain size and fewer brain neurons in DS and mouse models of DS, 
291 there are alterations in the structure of brain synapses that are predicted to modify synaptic 
292 function (Contestabile et al., 2017; Dierssen, 2012; Stagni et al., 2018). A previous study 
293 showed that DYRK1A overexpression in mice changes postsynaptic morphology in the cortex 
294 and in cultured cortical neurons by reducing the number and length of dendrites and by 
295 reducing the number of dendritic spines but elongating their shape (Martinez de Lagran et al., 
296 2012). It also decreased the number of synapses formed. Our study shows that mnb 
297 overexpression changes presynaptic structure and that this happens in a neuron-specific 
298 manner; mnb overexpression in the two glutamatergic motoneurons innervating the larval NMJ 
299 increased the number of 1b boutons without changing the number of 1s boutons. These data 
300 are consistent with a previous study which demonstrated that reduced levels of mnb caused 
301 a decrease, and increased levels of the mnb-F transcript an increase, in the number of boutons 
302 at the NMJ (Chen et al., 2014), but did not differentiate between 1b and 1s boutons. 
303
304 The cognitive and motor deficits in DS arise from aberrant information processing in the brain 
305 that is likely due, in part, to changes in synaptic transmission or synaptic plasticity. Individuals 
306 with DS have impaired synaptic plasticity in the motor cortex (Battaglia et al., 2008). Our 
307 finding that mnb overexpression slows replenishment of the readily releasable pool of vesicles, 
308 and also modifies basal synaptic transmission, confirms a previous suggestion that DYRK1A 
309 overexpression contributes to synaptic dysfunction and cognitive deficits associated with DS, 
310 made on the basis of the observed slowing of endocytosis of transmitter vesicles in cultured 
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311 mouse hippocampal neurons overexpressing human DYRK1A (Kim et al., 2010). The effects 
312 of DYRK1A on synaptic function may be splice variant specific as we found that 
313 overexpression of the mnb-H transcript caused a decrease in mEJP and EJP amplitude, 
314 whereas overexpression of mnb-F in a previous study  did not alter mEJP or EJP amplitude 
315 at the larval NMJ (Chen et al., 2014).  
316
317 The effects of neuronal mnb overexpression on larval NMJ function replicate some, but not 
318 all, the documented changes in glutamatergic synaptic transmission in the brain of mouse 
319 models of DS. These include a decrease in the amplitude of spontaneous excitatory 
320 postsynaptic currents (sEPSCs) in neocortical neurons of Ts65Dn mice (Cramer et al., 2015), 
321 compromised glutamate release in response to stimuli trains at hippocampal CA1 synapses 
322 of Ts1Cje mice (Siarey et al., 2005) and a decrease in EPSC amplitude in hippocampal CA3 
323 neurons of Ts65Dn mice (Hanson et al., 2007). However, in contrast to the increase in mEJP 
324 frequency caused by mnb overexpression at the larval NMJ, electrophysiological studies have 
325 found a decrease in the frequency of mEPSCs in hippocampal CA3 neurons of Ts65Dn mice, 
326 sEPSCs in neocortical neurons of Ts65Dn mice and sEPSCs in neurons derived from trisomy 
327 21 induced pluripotent stem cells, or no change in mEPSC frequency in the prefrontal cortex 
328 of TgDyrk1a mice or mossy fibre-CA3 synapses in Tc1 mice (Contestabile et al., 2017).
329
330 Our study further elucidates the effect of DYRK1A overexpression in a model system, giving 
331 insight into the contribution of increased dosage to various DS phenotypes. It supports the 
332 future development of pharmacological inhibitors of DYRK1A as treatments for multiple 
333 aspects of DS and DS-AD (Duchon and Herault, 2016; Stringer et al., 2017). Further work is 
334 necessary to fully understand interactions between DYRK1A and other triplicated Hsa21 






340 Materials and Methods
341 Animals
342 Flies were raised with a 12 h:12 h light dark cycle with lights on at ZT 0 (Zeitgeber time) on 
343 standard Drosophila medium (0.7% agar, 1.0% soya flour, 8.0% polenta/maize, 1.8% yeast, 
344 8.0% malt extract, 4.0% molasses, 0.8% propionic acid, 2.3% nipagen) at 25°C. Flies were 
345 transferred to vials containing fresh medium twice weekly. The OK371-Gal4 (Bloomington 
346 stock center numbers: 26160), Elav-Gal4 (87060), GMR-Gal4 (9146) flies were obtained from 
347 the Bloomington Drosophila Stock Centre. Canton Special white- (CSw-) flies were a gift from 
348 Dr Scott Waddell (University of Oxford), UAS-mnb flies (minibrain-H, CG42273) were kindly 
349 provided by Dr Kweon Yu (Korea Research Institute of Bioscience and Biotechnology), EB1-
350 Gal4; UAS-mCD8-GFP flies were donated by Dr Frank Hirth (Kings College London).  
351
352 Behaviour 
353 mnb expression was driven throughout the nervous system using Elav-Gal4 (Robinow and 
354 White, 1991) for experiments investigating behaviour of wandering third instar larvae, the 
355 number of boutons at the larval NMJ, and synaptic transmission at the larval NMJ. All 
356 behavioural experiments took place at 25oC. Larval locomotor experiments were conducted 
357 on a 9.5 cm petri dish containing 1.6% agarose. A single third instar wandering larva was 
358 selected, washed in a drop of distilled H2O, transferred to the agarose and allowed 30 s to 
359 acclimatise. To analyse free movement, the dish was placed over a 0.5 cm grid and the 
360 number of lines the larva crawled across in one minute was counted by eye. The self-righting 
361 assay was conducted as described elsewhere (Lowe et al., 2018; Picao-Osorio et al., 2015); 
362 the larva was gently rolled onto its back on the agarose using a fine moistened paintbrush, 
363 held for one second and released, and the time for it to right itself was recorded.
364
365 The negative geotaxis assay was performed as described previously (Ali et al., 2011). A cohort 
366 of 10 flies was transferred without anaesthesia to an empty 9.5 cm tube with a line drawn 2 
16
367 cm from the top. After 1 minute acclimatisation, the vial was sharply tapped 3 times to knock 
368 the flies to bottom. The number of flies to climb past the line within 10 s was recorded. 15 
369 cohorts of 10 flies were tested for each genotype. Age-dependent changes in climbing were 
370 assessed by repeating the negative geotaxis assay at 10, 20 and 30 days post-eclosure 
371 (Gargano et al., 2005). For the survival assay, 10 cohorts of 10 once-mated females were 
372 transferred to a vial of fresh food twice weekly and the number of surviving flies recorded at 
373 each transfer. 
374
375 Antibody staining and visualisation at the NMJ
376 Wandering third instar larvae were dissected in ice-cold, Ca2+-free HL3.1-like solution (in mM: 
377 70 NaCl, 5 KCl, 10 NaHCO3, 115 sucrose, 5 trehalose, 5 HEPES, 10 MgCl2) to produce a 
378 larval “fillet” (Brent et al., 2009). The fillet was fixed for 30 minutes in 4% paraformaldehyde 
379 (Sigma Labs), washed three times in 1% Triton-X (Sigma Labs) and blocked for one hour in 
380 5% normal goat serum (Fitzgerald Industries) and 1% Triton-X at room temperature. It was 
381 incubated overnight in 1/500 mouse FITC-conjugated anti-horseradish peroxidase (HRP-
382 FITC) (Jackson Immunoresearch Laboratories, 115-035-003) and 1/500 rabbit anti-Discs 
383 large (Dlg) (Biocompare, ABIN1387516) primary antibody, then for two hours in 1/500 
384 AlexaFluor 633-conjugated goat anti-mouse secondary antibody (ThermoFisher Scientific, A-
385 21052) at room temperature. Each fillet was washed and mounted on a coverslip in 
386 Vectashield (Vector Laboratories). Z-series of NMJs were imaged on a Leica SP5-II confocal 
387 laser-scanning microscope using an oil immersion 40 × objective. The number of boutons at 
388 the NMJ of muscle 6/7 in segment A2 was counted manually. ImageJ (rsb.info.nih.gov/ij/) was 
389 used to manually outline muscle 6 and hence calculate their area.
390
391 Neurotoxicity
392 Overexpression of mnb was driven in the eye using the Glass multimer reporter (GMR-Gal4). 
393 Images of the whole head of 1-2 day old flies were taken via a Zeiss AxioCam MRm camera 
394 attached to a stereomicroscope (Zeiss SteREO Discovery.V8, up to 8× magnification), and 
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395 the surface area of the eye was calculated by manually outlining the eye in ImageJ 
396 (rsb.info.nih.gov/ij/). Overexpression of mnb in GFP-tagged ellipsoid body (EB) ring neurons 
397 was achieved by crossing EB1-Gal4; UAS-mCD8-GFP flies with UAS-mnb flies. Following 
398 published methods (Williamson and Hiesinger, 2010), adult brains were dissected, fixed for 
399 30 minutes in 4% paraformaldehyde and mounted on a coverslip in Vectashield (Vector 
400 Laboratories). Slides were imaged on a Leica SP5-II confocal laser scanning microscope 
401 using an oil immersion 40 × objective. A Z-stack of 25 images at 1 μm increments was 
402 captured and combined into a 3-D projection using ImageJ (rsb.info.nih.gov/ij/); analysis was 




407 Wandering third instar larvae were dissected as for antibody staining. The motor nerves were 
408 severed just below the ventral ganglion and the brain was removed. CaCl2 (1 mM) was added 
409 to the bath solution for intracellular recording from muscle 6 of abdominal segments 2-4. Most 
410 recordings were made in the presence of thapsigargin (2 μM), which minimises contraction 
411 and hence facilitates intracellular recording, without affecting amplitudes of mEJPs or EJPs 
412 (Guerrero et al., 2005; Newman et al., 2017). Sharp microelectrodes (thick-walled borosilicate 
413 capillaries, pulled on a Sutter Flaming/Brown P-97 micropipette puller) were filled with 3M KCl 
414 and had resistances of 20-30 MΩ. For recording of stimulus evoked excitatory junction 
415 potentials (EJPs), severed nerves were drawn into a thin-walled glass-stimulating pipette and 
416 stimulated with square-wave voltage pulses (0.1 ms, 10 V, A-M Systems Model 2100 Isolated 
417 Pulse Simulator), 10 times at 0.1 Hz. EJPs and spontaneously-occurring miniature EJPs 
418 (mEJPs) were recorded at a controlled room temperature of 22-25°C with a Geneclamp 500 
419 amplifier (Axon Instruments) and were further amplified with a LHBF-48x amplifier (NPI 
420 Electronic). The membrane potential was allowed to stabilise for one minute, the initial value 
421 was recorded, and then set to -70 mV by injecting current with the Geneclamp 500 amplifier. 
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422 The muscle input resistance was measured by injecting current using the Axon Geneclamp 
423 500, to bring the membrane potential to -100, -80, -60 and -40 mV, and subtracting the 
424 electrode resistance from the slope of the resulting voltage/current graph. Voltage signals 
425 were low-pass filtered at 1.67 kHz (10 kHz 4 pole Bessel on Geneclamp 500, 1.7 kHz 8-pole 
426 Bessel on LHBF-48x) and digitised at 25 kHz by a CED-1401 plus A/D interface (Cambridge 
427 Electronic Design, UK) using Spike2 software (v. 5.13) (CED, Cambridge, UK). Recordings 
428 were discarded if the initial resting membrane potential was more positive than -60 mV or 
429 varied by more than 10% throughout the recording. Synaptic potentials were analysed off line 
430 using Strathclyde Electrophysiology Software WinEDR (v3.5.2) and GraphPad Prism (v.6).  All 
431 synaptic events were verified manually.
432
433 Amplitudes and intervals of mEJPs were compared by creating a cumulative distribution for 
434 each genotype of 1600 measurements across 8 animals, with each animal contributing 200 
435 values. To analyse the mEJP waveform, a mean mEJP was constructed for each recording 
436 from events showing a single clear peak and a smooth decay, so as to prevent distortion of 
437 the waveform by closely occurring mEJPs.  A single exponential was fitted to the decay of the 
438 mean mEJP and the 10-90% rise-time was measured. Time zero for the exponential fit was 
439 set to the time at the peak of the mEJP. EJPs were analysed by forming a mean of 10 events, 
440 measuring the 10-90% rise-time of the mean event, and fitting the decay with the sum of three 
441 exponentials (time zero was set at the time of the peak). A mean weighted time constant of 
442 decay was calculated as A1.τ1 + A2.τ2 + A3.τ3, where A1, A2 and A3 are the fractional amplitudes 
443 of the three components, and τ1, τ2 and τ3 are their time constants. 
444
445 For paired pulse analysis, two EJPs were evoked, separated with intervals varying in duration 
446 between 0.01 and 10 s. The amplitude of the second event was calculated as a fraction of the 
447 amplitude of the first. Pairs of stimuli were separated by 30 s. For high–frequency stimulation, 
448 trains of 10 events evoked at 10 Hz were repeated 8 times at 1 min intervals. The amplitude 
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449 of each event was expressed as a fraction of a baseline value, defined as the mean amplitude 
450 of 10 single EJPs evoked at 0.1 Hz. To compare mEJP amplitude before and after the trains, 
451 200 mEJP amplitudes were measured immediately before the first train, and another 200 
452 immediately after the eighth train. The measured values were pooled from 8 NMJs for each 
453 genotype and cumulative amplitude distributions compared.
454
455 Statistical analysis
456 Statistical analysis was conducted in GraphPad Prism (v. 6, La Jolla, CA). Data were tested 
457 for normality using the Kolmogorov-Smirnov test; where appropriate means were compared 
458 using Student’s unpaired t-test, or medians were compared using a Mann-Whitney U test. 
459 EJPs evoked by pairs or trains of stimuli were compared using repeated measures 2-way 
460 ANOVA. Cumulative distributions were compared with a Kolmogorov-Smirnov test. Survival 
461 curves were compared with a Mantel-Cox test. Data are given as median or mean ± SEM. n 
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672 Figure 1.  Motor deficits in larvae, accelerated age-dependent motor decline in adult 
673 flies and shortened adult lifespan due to neuronal overexpression of mnb
674 (A) Elav>mnb larvae crossed fewer lines of a 0.5 cm grid in 60 s than control larvae (Elav/+, 
675 14.7 ± 0.44, n = 15; Elav>mnb, 12.1 ± 0.86, n = 15; mean ± SEM, *P = 0.014, Student’s t-test), 
676 and with greater variance (F (14,14) = 3.768, P = 0.0184, F-test). (B) Elav>mnb larvae took 
24
677 longer than controls to perform a self-righting task (Elav/+, 5.5 ± 1.16 s, n = 15; Elav>mnb, 12 
678 ± 2.56 s; n = 15; mean ± SEM, *P = 0.029, Student’s t-test) and with greater variance (F 
679 (14,14) = 4.802, P = 0.0059, F-test). Each point in the plots (A, B) is from a different animal; 
680 horizontal lines indicate mean values. (C) The age-dependent decline in climbing ability in a 
681 negative geotaxis assay was steeper and showed greater variance for Elav>mnb adult flies 
682 than for controls (F (3,84) = 13.8; ***P< 0.0001, repeated measures two-way ANOVA, n = 15 
683 groups of flies); at 1 day old there was no difference in the percentage of flies that climbed 
684 successfully (Elav/+, 90.59 ± 1.82 %, n = 15; Elav>mnb ± 85.94 ± 1.46 %, n = 15; mean ± 
685 SEM, P = 0.8262, repeated measures two-way ANOVA and Sidak’s multiple comparison). 
686 Values plotted are mean ± SEM, n = 15 groups of 10 flies for each genotype. (D) Elav>mnb 
687 flies had a shorter lifespan relative to controls (n = 100 animals per genotype at day 0, ***P< 
688 0.0001, log-rank (Mantel-Cox) test).
689
690 Figure 2. Neurotoxicity and age-related neurodegeneration caused by mnb 
691 overexpression
692 (A) (Left) Representative images of the eyes of control adult flies (GMR/+) and flies with mnb 
693 overexpression driven in the eye by GMR-Gal4 (GMR>mnb). (Right) The surface area of the 
694 eyes in GMR>mnb flies was reduced (GMR/+, 0.14 ± 0.005 mm2, n = 10; GMR>mnb, 0.09 ± 
695 0.005 mm2, n = 10; mean ± SEM, ***P < 0.0001, Student’s t-test). Each point in the plot is from 
696 a different animal, horizontal lines indicate means. (B) (Left) Representative images of clusters 
697 of GFP-expressing ellipsoid body neurons in one brain hemisphere, with and without mnb 
698 overexpression driven by EB1-Gal4, in 1 d and 40 d old flies. Calibration bar is 10 μm. (Right) 
699 The number of cells did not differ at 1 d (EB1>mCD8-GFP; 32.59 ± 0.48, n = 15 (black); 
700 EB1>mCD8-GFP, mnb; 31.47 ± 0.47, n = 15 (grey); mean ± SEM, P = 0.757, repeated 
701 measures two-way ANOVA and Sidak’s multiple comparison) but decreased between 1 and 
702 40 d in EB1>mCD8-GFP, mnb flies; (F (1,28) = 10.56; n = 15; P = 0.003, repeated measures 
703 two-way ANOVA). Values plotted are mean ± SEM from 15 flies for each genotype.
704
25
705 Figure 3.  Overexpression of mnb in motor neurons increased the number of 1b boutons 
706 (A) Representative images of motor nerve endings at the NMJ of muscle 6/7 in the A2 segment 
707 of OK371/+ (top) and OK371>mnb (bottom) larvae. The neuronal membrane is labelled with 
708 HRP (green); type 1b boutons but not type 1s boutons (arrowheads) are preferentially labelled 
709 with Dlg (magenta). Scale bar is 25 μm. (B) OK371>mnb NMJs had more 1b boutons 
710 (OK371/+, 24.93 ± 1.11, n = 15; OK371>mnb, 32.80 ± 1.52, n = 15, mean ± SEM, ***P = 
711 0.0003, Student’s t-test) but there was no difference in the number of 1s boutons (OK371/+, 
712 32.6 ± 2.62, n = 15; OK371>mnb, 38.6 ± 3.34, n =15, mean ± SEM, P = 0.169, Student’s t-
713 test). Each value plotted is from a different animal, horizontal lines indicate means.
714
715 Figure 4. Overexpression of mnb in motor neurons altered basal synaptic transmission.
716 (A) Representative voltage recordings (3 s traces) from NMJs of OK371/+ (black) and 
717 OK371>mnb (grey) larvae showing spontaneous mEJPs recorded at a membrane potential of 
718 -70 mV. (B) Cumulative frequency distributions of mEJP amplitude (left) and inter-mEJP 
719 interval (right) (1600 events, 200 from each of 8 NMJ recordings). OK371>mnb mEJPs were 
720 smaller (***P < 0.0001) and more frequent (***P < 0.0001), Kolmogorov-Smirnov test. (C) 
721 (Left) Representative image of a single electrically-evoked EJP at an OK371/+ NMJ and an 
722 OK371>mnb NMJ at a membrane potential of -70 mV. (Right) The median EJP amplitude 
723 (horizontal line) was reduced in OK371>mnb NMJs (OK371/+, 51.26 mV, n = 8; OK371>mnb, 
724 45.55 mV, n = 8; mean ± SEM, *P = 0.0281). Each point plotted is from a different animal.
725
726 Figure 5. mnb overexpression in motor neurons slowed recovery from frequency-
727 induced depression
728 (A) (Left) Representative pairs of stimuli evoked EJPs at OK371/+ (black) and OK371>mnb 
729 (grey) NMJs. Dashed lines compare the first EJP (EJP1) and dotted lines compare the second 
730 EJP (EJP2). (Right) Plots of paired-pulse ratio (EJP2/EJP1, mean ± SEM, n = 8 for each 
731 genotype) against inter-pulse interval reveal no difference in synaptic depression (F (9, 126) 
732 = 0.1343; n = 8; P = 0.9987, repeated measures two-way ANOVA). (B) High-frequency 
26
733 stimulation protocol. 10 EJPs were evoked at 0.1 Hz to establish a mean baseline amplitude 
734 followed by 8 trains of 10 EJPs at 10 Hz, at one minute intervals. (Left) Representative traces 
735 of train 1 (upper) and train 8 (lower) recorded from OK371/+ and OK371>mnb NMJs. Dashed 
736 lines compare EJP1 in each train. (Right) Plots of EJP amplitude during trains 1 and 8, 
737 expressed as a fraction of baseline amplitude (mean ± SEM, n = 8 for each genotype). During 
738 the first train, the decline in EJP amplitude was unaffected by genotype (F (1, 14) = 0.22, P = 
739 0.6486, repeated measures two-way ANOVA). In the eighth train, EJPs were smaller at 
740 OK371>mnb NMJs (F (1,14) = 4.98, P = 0.0426) but the rate of decline during the 8th train was 
741 not different (F (9, 126) = 0.99, P = 0.4540, repeated measures two-way ANOVA). (C) 
742 Cumulative frequency distributions of mEJP amplitudes (n = 1600 from 8 NMJ recordings) 
743 from immediately before (solid line) and immediately after (dashed line) the trains, for OK371/+ 
744 (left) and OK371>mnb (right) NMJs; after the trains, a minority of mEJPs were larger in both 
745 OK371/+ (*P = 0.0117) and OK371>mnb (*P = 0.018) NMJs (log-rank (Mantel-Cox) test).
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